Dans le cadre du projet European Network for Baroque Cultural Heritage (ENBaCH), une équipe composée de jeunes chercheurs du Laboratoire Modernités et Révolutions (EA 127 - Paris 1), de chercheurs et d'ingénieurs de recherche du Groupe de Recherches ...
De Lima, Dora
core +1 more source
Does the Support of Innovative Clusters Sustainably Foster R&D Activity? Evidence from the German BioRegio and BioProfile Contests [PDF]
In this paper, we evaluate the R&D enhancing effects of two large public grant schemes aiming at encouraging the performance of firms organized in clusters. These are Germany's well known BioRegio and BioProfile contests for which we compare the research
D. Engel +3 more
core
Auctions for Government Securities: A Laboratory Comparison of Uniform, Discriminatory and Spanish Designs [PDF]
The Bank of Spain uses a unique auction format to sell government bonds, which can be seen as a hybrid of a uniform and a discriminatory auction. For winning bids above the average winning bid, buyers are charged the average winning bid, otherwise they ...
Jordi Brandts +2 more
core
Differences in the misreporting of chronic conditions, by level of education: the effect on inequalities in prevalence rates [PDF]
OBJECTIVES: Many studies of socio-economic inequalities in the prevalence of chronic conditions rely on self-reports. For chronic nonspecific lung disease, heart disease, and diabetes mellitus, we studied the effects of misreporting on ...
Looman, C.W.N. (Caspar) +2 more
core
Contribució a l'estudi dels fongs de Sant Joan de l'Erm i la Vall de Santa Magdalena (I) [PDF]
En aquesta zona dels Pirineus, a les comarques del nord de Lleida (Alt Urgell-Pallars Sobir á), els autors han identitificat 100 especies de fongs (2 mixomicets , 13 ascomicets , 1 teliomicet , 6 fragmobasidiomicets i 78 basidiomicets).
Carles Cortés, J. Montón
core +1 more source
Nicodémisme et déconfessionnalisation dans l’Europe de la première modernité
Jean-Pierre Cavaillé
doaj +1 more source
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience. [PDF]
Metzger-Filho O +14 more
europepmc +1 more source
Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study. [PDF]
Höffken K +6 more
europepmc +1 more source

